Previous 10 |
home / stock / repcf / repcf news
RepliCel Life Sciences ( OTCQB:REPCF ) announces the resumption of their First-in-Japan strategy. More news on: RepliCel Life Sciences Inc., Healthcare stocks news, Read more ...
RepliCel Reignites its First-in-Japan Strategy Canada NewsWire VANCOUVER, March 19, 2019 Next-stage trials in Japan present market launch opportunities for RepliCel's skin and tendon products VANCOUVER , March 19, 2019 /CNW/ - RepliCel Life Sciences Inc. (OTCQB: REP...
RepliCel Life Sciences ( OTCQB:REPCF ) has provided an update to shareholders. More news on: RepliCel Life Sciences Inc., Healthcare stocks news, Read more ...
With a new strategic plan, RepliCel prioritizes focus on commercial revenue VANCOUVER , March 5, 2019 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orth...
News, Short Squeeze, Breakout and More Instantly...
RepliCel Life Sciences Company Name:
REPCF Stock Symbol:
OTCMKTS Market:
RepliCel Life Sciences Website:
New DermaPrecise™ patent application and patents granted for tendinopathy and skin rejuvenation technologies in key markets VANCOUVER, BC / ACCESSWIRE / August 4, 2022 / RepliCel Life Sciences Inc. (OTCPK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company developi...
Independent Testing Performed by Innovacell Demonstrates the DermaPrecise ™ Control Leads to Unparalleled Post-Injection Cell Survival and Viability Consistency VANCOUVER, BC / ACCESSWIRE / August 2, 2022 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliC...
After over a year of pandemic-related delays, representatives of Japan's PMDA, attended at the Company's contract manufacturing facility, Innovacell, to review the manufacturing of RepliCel's NBDS cell therapy products VANCOUVER, BC / ACCESSWIRE / July 28, 2022 / RepliCel Life Sciences ...